Digestive System Diseases

633 trials 301 recruiting

Filter these 633 trials by phase, country and sponsor.

Open in Search →

Effect of Tofacitinib on coagulation and platelet function, and its role in thromboembolic events Recruiting

2024-518434-83-01 ulcerative colitis 6 2022-06-01
Pancreatitis and early omega-3-fatty acid infusion for reduction of organ failure and mortality. Recruiting

2023-505220-57-03 Predicted severe acute pancreatitis 5 2022-05-09
Improving Peptide Receptor Radionuclide Therapy with PARP inhibitors Recruiting

2024-513007-14-00 locally advanced or metastatic, well-differentiated gas 3 2022-03-24
Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy with systemic Nabpaclitaxel-Gemcitabine chemotherapy for pancreatic … Recruiting

2024-518938-81-00 Pancreatic cancer with peritoneal metastases 4 2022-03-09
A study of Vedulizumab in Children and Teenagers with Moderate to Severe Crohn's Disease (CD) Recruiting

2023-509045-13-00 Moderately to severely active Crohn's disease (CD) 5 2022-02-28
“NALPAC” A NON-COMPARATIVE RANDOMIZED PHASE 2 STUDY, EVALUATING THE EFFICACY OF 5-FU + NALIRI AND 5-FU + NALIRINOX FOR METASTATIC PANCREATIC… Recruiting

2024-516336-97-00 METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA 4 2022-02-21
Study of HM15912 in subjects with Short Bowel Syndrome-associated Intestinal Failure Recruiting

2024-515160-32-00 Short Bowel Syndrome-associated Intestinal Failure (SBS 4 2022-02-02
Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients Recruiting

2023-508594-84-00 Metastatic pancreatic adenocarcinoma 4 2022-01-11
Post-resection/ ablation chemotherapy in patients with metastatic colorectal cancer (FIRE-9 - PORT / AIO-KRK-0418). Prospective, randomized,… Recruiting

2024-512174-10-00 metastatic colorectal cancer 5 2021-11-11
Pharmacokinetics of apixaban in patients with short bowel syndrome requiring long-term parenteral nutrition. Recruiting

2024-512061-14-00 short bowel syndrome 6 2021-10-07
Fecal microbiota transplantation in Crohn’s disease as relay after anti-TNF withdrawal (MIRACLE) Recruiting

2024-511822-30-00 Crohn’s disease 11 2021-09-22
Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cance… Recruiting

2024-515344-23-00 local advenced pancreatic adenocarcinoma 4 2021-06-17
Clinical study to demonstrate the same clinical efficacy and tolerability of budesonide orodispersible tablets (taken twice a day compared t… Recruiting

2024-515229-26-00 eosinophilic esophagitis 5 2021-05-21
Stop of proton-pump inhibitor treatment in patients with liver cirrhosis – a doubleblind, placebo-controlled trial (STOPPIT) Recruiting

2023-509863-26-00 Liver cirrhosis 11 2021-04-29
Phase 1b/2 trial of 5-fluorouracil, leucovorin, irinotecan in combination with temozolomide (FLIRT) and bevacizumab for the first-line treat… Recruiting

2024-515580-64-00 metastatic colorectal cancer 7 2020-12-31
Multicentre, open-label, randomized, controlled, parallel arms clinical trial of induction chemotherapy followed by chemoradiotherapy versus… Recruiting

2024-512526-28-00 Locally recurrent rectal cancer 5 2020-10-28
A comparison of the effect of autologous bone marrow-derived mononuclear cell therapy with standard treatment on ischemia parameters in diab… Recruiting

2024-519687-40-00 diabetic foot syndrome 10 2020-09-11
Controlled clinical trial to investigate the efficacy and safety of MYRRHINIL-INTEST® versus placebo in patients with diarrhoea-dominant irr… Recruiting

2024-514383-61-00 Diarrhoea predominant irritable bowel syndrome 6 2020-07-07
Controlled clinical trial to investigate the efficacy and safety of MYRRHINIL-INTEST® versus placebo in patients with diarrhoea-dominant irr… Recruiting

2024-514892-16-00 Diarrhoea predominant irritable bowel syndrome 6 2020-05-05
Pharmacokinetics of antibiotics in bile fluid of patients with external biliary drainage Recruiting

2024-517165-17-00 Cholangitis 3 2020-02-03
An open-label randomized trial COmparing staNdard of care versus Treat to target with telemonitoRing and patient education in patients with … Recruiting

2023-507256-76-00 Ulcerative colitis 6 2020-01-14
Randomized, double-blind, placebo-controlled, multi-centre trial to evaluate the efficacy, safety and tolerability of oral treatment with li… Recruiting

2024-512104-19-00 Irritable Bowel Syndrome 6 2019-11-19
SGM-LARRC: Multicenter, open-label, controlled, parallel arms clinical study on the performance of SGM-101, a fluorochrome-labeled anti-carc… Recruiting

2024-510768-21-00 Rectal cancer 4 2019-10-16
Neoadjuvant treatment in rectal cancer with radiotherapy followed by atezolizumab and bevacizumab Recruiting

2024-517119-59-00 Rectal cancer 4 2019-09-26